{"pmid":32363228,"pmcid":"PMC7194991","title":"Art of prevention: Life in the time of coronavirus.","text":["Art of prevention: Life in the time of coronavirus.","The novel coronavirus disease 2019 (COVID-19) has continued to progress since its discovery in December 2019. A cluster of patients with atypical pneumonia identified in Wuhan, China, served as the epicenter of this recent epidemic. This family of viruses is responsible for the common cold along with the infamous severe acute respiratory syndrome epidemic in 2002 and Middle East respiratory syndrome in 2012. The Southern China Wholesale Market reportedly has connections to the original 27 cases in Wuhan, China. The worldwide confirmed case total has eclipsed 1,450,000, with more than 83,000 deaths. Patient presentation ranges from mild respiratory illness to acute respiratory distress syndrome and subsequent death. Early epidemiologic studies of viral spread support the hypothesis that COVID-19 can remain latent with an extended and infectious incubation period. The U.S. government has issued level 3 precautions for most international travel, along with prohibiting entry to foreign nationals traveling from China, Iran, the United Kingdom, the Republic of Ireland, and the European Schengen area (e.g., France, Italy, Germany). Prevention remains the mainstay in treating and defeating the COVID-19 epidemic. Anyone infected or suspected of being infected should self-quarantine at home or admit themselves to a specified hospital with infrastructure to handle the situation. The combination of prevention and containment provides the best opportunity to stall the spread of COVID-19.","Int J Womens Dermatol","Baghchechi, Mohsen","Dunn, Jeffery","Jaipaul, Navin","Jacob, Sharon E","32363228"],"abstract":["The novel coronavirus disease 2019 (COVID-19) has continued to progress since its discovery in December 2019. A cluster of patients with atypical pneumonia identified in Wuhan, China, served as the epicenter of this recent epidemic. This family of viruses is responsible for the common cold along with the infamous severe acute respiratory syndrome epidemic in 2002 and Middle East respiratory syndrome in 2012. The Southern China Wholesale Market reportedly has connections to the original 27 cases in Wuhan, China. The worldwide confirmed case total has eclipsed 1,450,000, with more than 83,000 deaths. Patient presentation ranges from mild respiratory illness to acute respiratory distress syndrome and subsequent death. Early epidemiologic studies of viral spread support the hypothesis that COVID-19 can remain latent with an extended and infectious incubation period. The U.S. government has issued level 3 precautions for most international travel, along with prohibiting entry to foreign nationals traveling from China, Iran, the United Kingdom, the Republic of Ireland, and the European Schengen area (e.g., France, Italy, Germany). Prevention remains the mainstay in treating and defeating the COVID-19 epidemic. Anyone infected or suspected of being infected should self-quarantine at home or admit themselves to a specified hospital with infrastructure to handle the situation. The combination of prevention and containment provides the best opportunity to stall the spread of COVID-19."],"journal":"Int J Womens Dermatol","authors":["Baghchechi, Mohsen","Dunn, Jeffery","Jaipaul, Navin","Jacob, Sharon E"],"date":"2020-05-05T11:00:00Z","year":2020,"_id":"32363228","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.ijwd.2020.03.046","keywords":["coronavirus","epidemic","infection control","prevention"],"locations":["Wuhan","China","Wuhan","China","USA","China","Iran","United Kingdom","France","Italy","Germany"],"countries":["Germany","United Kingdom","China","Iran, Islamic Republic of","United States","Italy","France"],"countries_codes":["DEU|Germany","GBR|United Kingdom","CHN|China","IRN|Iran, Islamic Republic of","USA|United States","ITA|Italy","FRA|France"],"topics":["Prevention"],"weight":1,"_version_":1666138495973851136,"score":9.490897,"similar":[{"pmid":32347974,"title":"Metformin and COVID-19: A novel deal of an Old Drug.","text":["Metformin and COVID-19: A novel deal of an Old Drug.","In 2002, China witnessed the emergence of a severe acute respiratory disease caused by coronavirus SARS-CoV. Ten years later in 2012 a new version of the virus appeared in the Middle East known as Middle East Respiratory Syndrome Coronavirus MERS-CoV. At the end of 2019, the Chinese Center for Disease Control and Prevention (China CDC) recorded a pneumonia of unknown causes. Epidemiologically, the pneumonia was linked to a wet animal and seafood wholesale market in Wuhan, Hubei Province, China, later Known by COVID-19. The COVID-19 is a global pandemic infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Till now the total number of confirmed cases is 2,709,483 in over 225 countries around the world. A recent report indicates that obesity may responsible for increasing the mortality of COVID-19 in Italy rather than in China. Here we would like to shed light on a new suggestion to decrease the mortality rate of COVID-19. This article is protected by copyright. All rights reserved.","J Med Virol","El-Arabey, Amr Ahmed","Abdalla, Mohnad","32347974"],"abstract":["In 2002, China witnessed the emergence of a severe acute respiratory disease caused by coronavirus SARS-CoV. Ten years later in 2012 a new version of the virus appeared in the Middle East known as Middle East Respiratory Syndrome Coronavirus MERS-CoV. At the end of 2019, the Chinese Center for Disease Control and Prevention (China CDC) recorded a pneumonia of unknown causes. Epidemiologically, the pneumonia was linked to a wet animal and seafood wholesale market in Wuhan, Hubei Province, China, later Known by COVID-19. The COVID-19 is a global pandemic infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Till now the total number of confirmed cases is 2,709,483 in over 225 countries around the world. A recent report indicates that obesity may responsible for increasing the mortality of COVID-19 in Italy rather than in China. Here we would like to shed light on a new suggestion to decrease the mortality rate of COVID-19. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["El-Arabey, Amr Ahmed","Abdalla, Mohnad"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32347974","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1002/jmv.25958","keywords":["covid-19","diabetic","metformin","obesity","older","pneumonia"],"locations":["China","Wuhan","Hubei","China","Italy","China"],"countries":["Italy","China"],"countries_codes":["ITA|Italy","CHN|China"],"e_drugs":["Metformin"],"topics":["Treatment"],"weight":1,"_version_":1666138494928420865,"score":208.1875},{"pmid":32237160,"title":"Epidemiological analysis of COVID-19 and practical experience from China.","text":["Epidemiological analysis of COVID-19 and practical experience from China.","The rapid spread of the epidemic has aroused widespread concern in the international community. Severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) was first reported in China, with bats as the likely original hosts and pangolins as potential intermediate hosts. The current source of the disease is mainly patients infected with SARS-COV-2. Patients in the incubation period may also become sources of infection. The virus is mainly transmitted via respiratory droplets and contact, and the population is generally susceptible. The epidemic has progressed through the local outbreak stage and community transmission stage due to exposure at Wuhan's Huanan wholesale seafood market and is now in the stage of large-scale transmission due to the spread of the epidemic. The basic productive number (R0) at the beginning of the epidemic was 2.2, with an average incubation period of 5.2 days. The proportion of critically ill patients was 23.4%, the mortality rate was lower than those of SARS and Middle East respiratory syndrome, and 96.5% of deaths occurred in Hubei Province, where the outbreak occurred first. Among them, elderly men with underlying diseases had a higher mortality rate. Chinese medical staff have summarized a set of effective strategies and methods in the diagnosis and treatment of this disease that are worthy of reference for their international counterparts. With powerful government intervention and the efforts of Chinese medical staff, China's outbreak has gradually improved.","J Med Virol","Ye, Qing","Wang, Bili","Mao, Jianhua","Fu, Junfen","Shang, Shiqiang","Shu, Qiang","Zhang, Ting","32237160"],"abstract":["The rapid spread of the epidemic has aroused widespread concern in the international community. Severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) was first reported in China, with bats as the likely original hosts and pangolins as potential intermediate hosts. The current source of the disease is mainly patients infected with SARS-COV-2. Patients in the incubation period may also become sources of infection. The virus is mainly transmitted via respiratory droplets and contact, and the population is generally susceptible. The epidemic has progressed through the local outbreak stage and community transmission stage due to exposure at Wuhan's Huanan wholesale seafood market and is now in the stage of large-scale transmission due to the spread of the epidemic. The basic productive number (R0) at the beginning of the epidemic was 2.2, with an average incubation period of 5.2 days. The proportion of critically ill patients was 23.4%, the mortality rate was lower than those of SARS and Middle East respiratory syndrome, and 96.5% of deaths occurred in Hubei Province, where the outbreak occurred first. Among them, elderly men with underlying diseases had a higher mortality rate. Chinese medical staff have summarized a set of effective strategies and methods in the diagnosis and treatment of this disease that are worthy of reference for their international counterparts. With powerful government intervention and the efforts of Chinese medical staff, China's outbreak has gradually improved."],"journal":"J Med Virol","authors":["Ye, Qing","Wang, Bili","Mao, Jianhua","Fu, Junfen","Shang, Shiqiang","Shu, Qiang","Zhang, Ting"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32237160","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1002/jmv.25813","keywords":["covid-19","epidemic","mortality","treatment","virus pneumonia"],"locations":["China","Wuhan","Huanan","Hubei","Chinese","Chinese","China","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1666138490312589313,"score":206.1297},{"pmid":32341630,"pmcid":"PMC7179067","title":"Tackling Corona Virus Disease 2019 (COVID 19) in Workplaces.","text":["Tackling Corona Virus Disease 2019 (COVID 19) in Workplaces.","Coronaviruses are zoonotic viruses and six species of Coronaviruses are known to cause human disease such as cause common cold, severe acute respiratory syndrome and the Middle East Respiratory Syndrome. In January 2020, scientists in Wuhan, China isolated a novel coronavirus (SARS-CoV-2), responsible for an outbreak of unknown pneumonia that had not been previously reported among humans. This virus spreads from person to person, through respiratory droplets, close contact, and by touching surfaces or objects contaminated by the virus. The incubation period varies between 2 days and 14 days. Symptoms usually include fever, cough, difficulty in breathing, pneumonia, severe acute respiratory syndrome. Older age and co-morbid conditions increase the fatality. Any person with a history of travel to and from COVID-19 affected countries in the past 14 days or any person who has had close contact with a laboratory confirmed COVID-19 are suspect cases and needs evaluation. Currently no vaccine is available and treatment is mainly supportive. Measures at workplace should include- avoiding non-essential travel, identifying and isolating sick employees at the earliest, hand hygiene, respiratory hygiene, environmental hygiene and social distancing.","Indian J Occup Environ Med","Ramesh, Naveen","Siddaiah, Archana","Joseph, Bobby","32341630"],"abstract":["Coronaviruses are zoonotic viruses and six species of Coronaviruses are known to cause human disease such as cause common cold, severe acute respiratory syndrome and the Middle East Respiratory Syndrome. In January 2020, scientists in Wuhan, China isolated a novel coronavirus (SARS-CoV-2), responsible for an outbreak of unknown pneumonia that had not been previously reported among humans. This virus spreads from person to person, through respiratory droplets, close contact, and by touching surfaces or objects contaminated by the virus. The incubation period varies between 2 days and 14 days. Symptoms usually include fever, cough, difficulty in breathing, pneumonia, severe acute respiratory syndrome. Older age and co-morbid conditions increase the fatality. Any person with a history of travel to and from COVID-19 affected countries in the past 14 days or any person who has had close contact with a laboratory confirmed COVID-19 are suspect cases and needs evaluation. Currently no vaccine is available and treatment is mainly supportive. Measures at workplace should include- avoiding non-essential travel, identifying and isolating sick employees at the earliest, hand hygiene, respiratory hygiene, environmental hygiene and social distancing."],"journal":"Indian J Occup Environ Med","authors":["Ramesh, Naveen","Siddaiah, Archana","Joseph, Bobby"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32341630","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.4103/ijoem.IJOEM_49_20","keywords":["containment","sars-cov 2","prevention","travel","workplace"],"locations":["Coronaviruses","Wuhan","China","Workplaces"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Treatment","Prevention"],"weight":1,"_version_":1666138495808176128,"score":196.32649},{"pmid":32050635,"pmcid":"PMC7077337","title":"Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections.","text":["Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections.","In early December 2019 a cluster of cases of pneumonia of unknown cause was identified in Wuhan, a city of 11 million persons in the People's Republic of China. Further investigation revealed these cases to result from infection with a newly identified coronavirus, termed the 2019-nCoV. The infection moved rapidly through China, spread to Thailand and Japan, extended into adjacent countries through infected persons travelling by air, eventually reaching multiple countries and continents. Similar to such other coronaviruses as those causing the Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS), the new coronavirus was reported to spread via natural aerosols from human-to-human. In the early stages of this epidemic the case fatality rate is estimated to be approximately 2%, with the majority of deaths occurring in special populations. Unfortunately, there is limited experience with coronavirus infections during pregnancy, and it now appears certain that pregnant women have become infected during the present 2019-nCoV epidemic. In order to assess the potential of the Wuhan 2019-nCoV to cause maternal, fetal and neonatal morbidity and other poor obstetrical outcomes, this communication reviews the published data addressing the epidemiological and clinical effects of SARS, MERS, and other coronavirus infections on pregnant women and their infants. Recommendations are also made for the consideration of pregnant women in the design, clinical trials, and implementation of future 2019-nCoV vaccines.","Viruses","Schwartz, David A","Graham, Ashley L","32050635"],"abstract":["In early December 2019 a cluster of cases of pneumonia of unknown cause was identified in Wuhan, a city of 11 million persons in the People's Republic of China. Further investigation revealed these cases to result from infection with a newly identified coronavirus, termed the 2019-nCoV. The infection moved rapidly through China, spread to Thailand and Japan, extended into adjacent countries through infected persons travelling by air, eventually reaching multiple countries and continents. Similar to such other coronaviruses as those causing the Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS), the new coronavirus was reported to spread via natural aerosols from human-to-human. In the early stages of this epidemic the case fatality rate is estimated to be approximately 2%, with the majority of deaths occurring in special populations. Unfortunately, there is limited experience with coronavirus infections during pregnancy, and it now appears certain that pregnant women have become infected during the present 2019-nCoV epidemic. In order to assess the potential of the Wuhan 2019-nCoV to cause maternal, fetal and neonatal morbidity and other poor obstetrical outcomes, this communication reviews the published data addressing the epidemiological and clinical effects of SARS, MERS, and other coronavirus infections on pregnant women and their infants. Recommendations are also made for the consideration of pregnant women in the design, clinical trials, and implementation of future 2019-nCoV vaccines."],"journal":"Viruses","authors":["Schwartz, David A","Graham, Ashley L"],"date":"2020-02-14T11:00:00Z","year":2020,"_id":"32050635","source":"PubMed","week":"20207|Feb 10 - Feb 16","doi":"10.3390/v12020194","keywords":["2019-ncov","china","mers-cov","middle east respiratory syndrome","sars-cov","wuhan coronavirus","wuhan coronavirus outbreak","coronavirus","emerging infection","epidemic","maternal death","maternal morbidity","maternal mortality","pneumonia","pregnancy","pregnancy complications","severe acute respiratory syndrome"],"locations":["Wuhan","China","Thailand","Japan","Wuhan"],"countries":["Thailand","Japan","China"],"countries_codes":["THA|Thailand","JPN|Japan","CHN|China"],"topics":["Treatment"],"weight":1,"_version_":1666138493003235329,"score":194.56221},{"pmid":32245083,"pmcid":"PMC7157541","title":"SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far.","text":["SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far.","In December 2019, a cluster of fatal pneumonia cases presented in Wuhan, China. They were caused by a previously unknown coronavirus. All patients had been associated with the Wuhan Wholefood market, where seafood and live animals are sold. The virus spread rapidly and public health authorities in China initiated a containment effort. However, by that time, travelers had carried the virus to many countries, sparking memories of the previous coronavirus epidemics, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), and causing widespread media attention and panic. Based on clinical criteria and available serological and molecular information, the new disease was called coronavirus disease of 2019 (COVID-19), and the novel coronavirus was called SARS Coronavirus-2 (SARS-CoV-2), emphasizing its close relationship to the 2002 SARS virus (SARS-CoV). The scientific community raced to uncover the origin of the virus, understand the pathogenesis of the disease, develop treatment options, define the risk factors, and work on vaccine development. Here we present a summary of current knowledge regarding the novel coronavirus and the disease it causes.","Pathogens","Rabi, Firas A","Al Zoubi, Mazhar S","Kasasbeh, Ghena A","Salameh, Dunia M","Al-Nasser, Amjad D","32245083"],"abstract":["In December 2019, a cluster of fatal pneumonia cases presented in Wuhan, China. They were caused by a previously unknown coronavirus. All patients had been associated with the Wuhan Wholefood market, where seafood and live animals are sold. The virus spread rapidly and public health authorities in China initiated a containment effort. However, by that time, travelers had carried the virus to many countries, sparking memories of the previous coronavirus epidemics, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), and causing widespread media attention and panic. Based on clinical criteria and available serological and molecular information, the new disease was called coronavirus disease of 2019 (COVID-19), and the novel coronavirus was called SARS Coronavirus-2 (SARS-CoV-2), emphasizing its close relationship to the 2002 SARS virus (SARS-CoV). The scientific community raced to uncover the origin of the virus, understand the pathogenesis of the disease, develop treatment options, define the risk factors, and work on vaccine development. Here we present a summary of current knowledge regarding the novel coronavirus and the disease it causes."],"journal":"Pathogens","authors":["Rabi, Firas A","Al Zoubi, Mazhar S","Kasasbeh, Ghena A","Salameh, Dunia M","Al-Nasser, Amjad D"],"date":"2020-04-05T11:00:00Z","year":2020,"_id":"32245083","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.3390/pathogens9030231","keywords":["covid-19","coronavirus","sars","sars-cov-2","wuhan","pandemic"],"locations":["Wuhan","China","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Treatment","Diagnosis"],"weight":1,"_version_":1666138492019671040,"score":190.59315}]}